B+
Bull case
20%
Probability
Target price
$114.50
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
LNTH
LantheusCNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
The Curium transaction provides a $102.50 cash anchor, potential CVR upside to $114.50, and a strategic combination spanning diagnostics and therapeutics. Lantheus also reported $92.2 million of operating cash flow and $593.3 million of cash at June 30, 2026.
Posture
Mixed
Lead driver
Sentiment
What changed
1 setup hits (3d) with net bullish as of 2026-09-10.
What can break
Curium transaction completion could be delayed or fail, leaving the stock exposed to standalone repricing.
Momentum
40
Value
61
Sentiment
65
Setup hits (3d)
1 · Net Bullish
AI TargetsBase $102.50 · Bull $114.50 · Bear $88.00Analysis 2026-08-08; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-08 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Bullish
Target $106.84
Why
Momentum40 · Δ7d +13.4
Value61 · Δ7d -0.0
Sentiment65 · Δ7d +6.7
So what
Balanced signals (Net Bullish). Wait for confirmation before sizing up.
Confirming evidence
- • 1 setup hits (3d) with net bullish as of 2026-09-10.
- • Sentiment remains the lead driver in the composite, 7D delta +6.7.
Contradictions & invalidation
- • Curium transaction completion could be delayed or fail, leaving the stock exposed to standalone repricing.
- • Lantheus suspended previously issued full-year 2026 guidance and will not hold a Q2 earnings call, reducing forward disclosure.
- • Standalone momentum remains modest: Q2 revenue grew only 2.7%, PYLARIFY declined 4.1%, and adjusted EPS declined 1.3%.
Catalyst clock
2026-08-06
Q2 results were operationally mixed and guidance was suspended
Lead driver: Sentiment · See AI snapshot
Momentum
40
9% active weight
Current posture
7d trendImproving
Δ7d
+13.4
Δ21d
-2.8
Value
61
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
-0.4
Sentiment
65
62% active weight
Current posture
7d trendImproving
Δ7d
+6.7
Δ21d
+1.8
Why this grade
Composite grade C. Momentum 39.9 / Value 60.6 / Sentiment 65.2
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-08. Scenario method
Most likely
B
Base case
60%
Probability
Target price
$102.50
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
B-
Bear case
20%
Probability
Target price
$88.00
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$6.59B
Beta
-0.08
Shares Out
65.27M
P/E (TTM)
29.0
P/S (TTM)
3.00
P/FCF (TTM)
11.05
Rev YoY
+2.7%
EPS YoY
-0.8%
Gross Margin
+60.1%
Op Margin
+19.5%
Net Debt
$264.12M
Current Ratio
3.06
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data